Upregulation of DMT1 Expression in Choroidal Epithelia of the Blood-CSF Barrier Following Manganese Exposure in Vitro

Overview

Journal Brain Res

Specialty Neurology

Date 2006 May 30

PMID 16729984

Citations 32

Authors

Xueqian Wang

Guojun Jane Li

Wei Zheng

Affiliations

Soon will be listed here.

Abstract

Divalent metal transporter 1 (DMT1), whose mRNA possesses a stem-loop structure in 3'-untranslated region, has been identified in most organs and responsible for transport of various divalent metal ions. Previous work from this laboratory has shown that manganese (Mn) exposure alters the function of iron regulatory protein (IRP) and increases iron (Fe) concentrations in the cerebrospinal fluid (CSF). This study was designed to test the hypothesis that Mn treatment, by acting on protein-mRNA binding between IRP and DMT1 mRNA, altered the expression of DMT1 in an immortalized choroidal epithelial Z310 cell line which was derived from rat choroid plexus epithelia, leading to a compartmental shift of Fe from the blood to the CSF. Immunocytochemistry confirmed the presence of DMT1 in Z310 cell. Following in vitro exposure to Mn at 100 microM for 24 and 48 h, the expression of DMT1 mRNA in Z310 cells was significantly increased by 45.4% (P < 0.05) and 78.1% (P < 0.01), respectively, as compared to controls. Accordingly, Western blot analysis revealed a significant increase of DMT1 protein concentrations at 48 h after Mn exposure (100 microM). Electrophoretic mobility shift assay (EMSA) showed that Mn exposure increased binding of IRP to DMT1 mRNA in cultured choroidal Z310 cells. Moreover, real-time RT-PCR revealed no changes in DMT1 heterogeneous nuclear RNA (hnRNA) levels following Mn exposure. These data suggest that Mn appears to stabilize the binding of IRP to DMT1 mRNA, thereby increasing the expression of DMT1. The facilitated transport of Fe by DMT1 at the blood-CSF barrier may partly contribute to Mn-induced neurodegenerative Parkinsonism.

Citing Articles

In Vitro Models of the Blood-Cerebrospinal Fluid Barrier and Their Applications in the Development and Research of (Neuro)Pharmaceuticals.

Dabbagh F, Schroten H, Schwerk C Pharmaceutics. 2022; 14(8).

PMID: 36015358 PMC: 9412499. DOI: 10.3390/pharmaceutics14081729.

Manganese methionine hydroxy analog chelated affects growth performance, trace element deposition and expression of related transporters of broilers.

Meng T, Gao L, Xie C, Xiang Y, Huang Y, Zhang Y Anim Nutr. 2021; 7(2):481-487.

PMID: 34258436 PMC: 8245798. DOI: 10.1016/j.aninu.2020.09.005.

Effects of Vitamin C and Magnesium L-threonate Treatment on Learning and Memory in Lead-poisoned Mice.

Bislimi K, Mazreku I, Halili J, Aliko V, Sinani K, Hoxha L J Vet Res. 2021; 65(2):217-223.

PMID: 34250307 PMC: 8256468. DOI: 10.2478/jvetres-2021-0032.

Protective Effects of Sodium Para-aminosalicylic Acid on Manganese-Induced Damage in Rat Pancreas.

Zhu X, Xie B, Liang D, Qin W, Zhao L, Deng Y Biol Trace Elem Res. 2021; 199(10):3759-3771.

PMID: 33405079 DOI: 10.1007/s12011-020-02516-x.

Cross-sectional study of expression of divalent metal transporter-1, transferrin, and hepcidin in blood of smelters who are occupationally exposed to manganese.

Fan Q, Zhou Y, Yu C, Chen J, Shi X, Zhang Y PeerJ. 2016; 4:e2413.

PMID: 27635361 PMC: 5012280. DOI: 10.7717/peerj.2413.

References

Zheng W, Zhao Q, Slavkovich V, Aschner M, Graziano J . Alteration of iron homeostasis following chronic exposure to manganese in rats. Brain Res. 1999; 833(1):125-32. PMC: 4126166. DOI: 10.1016/s0006-8993(99)01558-9. View

Levy J, Jin O, Fujiwara Y, Kuo F, Andrews N . Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat Genet. 1999; 21(4):396-9. DOI: 10.1038/7727. View

Meyron-Holtz E, Ghosh M, Rouault T . Mammalian tissue oxygen levels modulate iron-regulatory protein activities in vivo. Science. 2004; 306(5704):2087-90. DOI: 10.1126/science.1103786. View

Li G, Zhao Q, Zheng W . Alteration at translational but not transcriptional level of transferrin receptor expression following manganese exposure at the blood-CSF barrier in vitro. Toxicol Appl Pharmacol. 2005; 205(2):188-200. PMC: 3980884. DOI: 10.1016/j.taap.2004.10.003. View

Reaney S, Smith D . Manganese oxidation state mediates toxicity in PC12 cells. Toxicol Appl Pharmacol. 2005; 205(3):271-81. DOI: 10.1016/j.taap.2004.10.013. View

Konarska M, Sharp P . Electrophoretic separation of complexes involved in the splicing of precursors to mRNAs. Cell. 1986; 46(6):845-55. DOI: 10.1016/0092-8674(86)90066-8. View

Andrews N . The iron transporter DMT1. Int J Biochem Cell Biol. 1999; 31(10):991-4. DOI: 10.1016/s1357-2725(99)00065-5. View

Roth J, Horbinski C, Feng L, Dolan K, Higgins D, Garrick M . Differential localization of divalent metal transporter 1 with and without iron response element in rat PC12 and sympathetic neuronal cells. J Neurosci. 2000; 20(20):7595-601. PMC: 6772877. View

Georgieff M, Wobken J, Welle J, Burdo J, Connor J . Identification and localization of divalent metal transporter-1 (DMT-1) in term human placenta. Placenta. 2000; 21(8):799-804. DOI: 10.1053/plac.2000.0566. View

10.

Zheng W, Zhao Q . Iron overload following manganese exposure in cultured neuronal, but not neuroglial cells. Brain Res. 2001; 897(1-2):175-9. PMC: 3980869. DOI: 10.1016/s0006-8993(01)02049-2. View

11.

Ferguson C, Wareing M, Ward D, Green R, Smith C, Riccardi D . Cellular localization of divalent metal transporter DMT-1 in rat kidney. Am J Physiol Renal Physiol. 2001; 280(5):F803-14. DOI: 10.1152/ajprenal.2001.280.5.F803. View

12.

Walker N . Real-time and quantitative PCR: applications to mechanism-based toxicology. J Biochem Mol Toxicol. 2001; 15(3):121-7. DOI: 10.1002/jbt.8. View

13.

Lin E, Graziano J, Freyer G . Regulation of the 75-kDa subunit of mitochondrial complex I by iron. J Biol Chem. 2001; 276(29):27685-92. DOI: 10.1074/jbc.M100941200. View

14.

Chen J, Tsao G, Zhao Q, Zheng W . Differential cytotoxicity of Mn(II) and Mn(III): special reference to mitochondrial [Fe-S] containing enzymes. Toxicol Appl Pharmacol. 2001; 175(2):160-8. PMC: 4126157. DOI: 10.1006/taap.2001.9245. View

15.

Rouault T . Systemic iron metabolism: a review and implications for brain iron metabolism. Pediatr Neurol. 2001; 25(2):130-7. DOI: 10.1016/s0887-8994(01)00260-0. View

16.

Burdo J, Menzies S, Simpson I, Garrick L, Garrick M, Dolan K . Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J Neurosci Res. 2001; 66(6):1198-207. DOI: 10.1002/jnr.1256. View

17.

Gunshin H, Allerson C, Rofts A, Rogers J, Kishi F, Hentze M . Iron-dependent regulation of the divalent metal ion transporter. FEBS Lett. 2001; 509(2):309-16. DOI: 10.1016/s0014-5793(01)03189-1. View

18.

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

19.

Takeda A, Takatsuka K, Sotogaku N, Oku N . Influence of iron-saturation of plasma transferrin in iron distribution in the brain. Neurochem Int. 2002; 41(4):223-8. DOI: 10.1016/s0197-0186(02)00023-2. View

20.

Siddappa A, Rao R, Wobken J, Leibold E, Connor J, Georgieff M . Developmental changes in the expression of iron regulatory proteins and iron transport proteins in the perinatal rat brain. J Neurosci Res. 2002; 68(6):761-75. DOI: 10.1002/jnr.10246. View